ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)
| 20.73 Data as of Jul 23 |  +0.57 / +2.83%Today’s Change | 15.64 Today|||52-Week Range 32.00 | -17.05% Year-to-Date |
Latest ACAD News | Press Releases
No recent news for ACADIA Pharmaceuticals Inc.
Today’s Trading
| Previous close | 20.16 |
| Today’s open | 20.34 |
| Day’s range | 20.34 - 20.87 |
| Volume | 1,079,604 |
| Average volume (3 months) | 1,286,833 |
| Market cap | $2.0B |
| Dividend yield | -- |
Data as of 4:00pm ET, 07/23/2014
Growth & Valuation
| Earnings growth (last year) | -15.79% |
| Earnings growth (this year) | -80.68% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -76.67% |
| P/E ratio | NM |
| Price/Sales | 1,870.76 |
| Price/Book | 10.08 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IRWDIronwood Pharmaceuti... | +0.58 | +4.01% |
| IPXLImpax Laboratories I... | -0.07 | -0.24% |
| PBYIPuma Biotechnology I... | +174.40 | +295.44% |
| GWPHGW Pharmaceuticals P... | -1.56 | -1.77% |
Data as of 4:00pm ET, 07/23/2014
Financials
| Next reporting date | August 6, 2014 |
| EPS forecast (this quarter) | -$0.19 |
| Annual revenue (last year) | $1.1M |
| Annual profit (last year) | -$37.9M |
| Net profit margin | -3,314.24% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, CEO, Director & CAO Uli Hacksell |
Executive VP, Chief Financial & Business Officer Stephen R. Davis |
Corporate headquarters San Diego, California |
Forecasts
